San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians
SESSION I - Risk Factors and Prevention
San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians
Approaches to Treating Diabetes that Reduce CV Events: How Effective Are DPP-4 Inhibitors, GLP1-Receptor Agonists and SGLT-2 Inhibitors in Reducing MACE and Preventing HF Events?
FEATURING
Jia Shen
- 343 views
- February 5, 2021
- 4
San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians
Novelties in Lipid Lowering Therapies: Can Statin Therapy Reduce Residual Risk? How Promising Are Icosapent Ethyl, Bampedoic Acid, Inclisiran and Evinacumab for Treating the Patients?
FEATURING
Pam Taub
- 925 views
- February 5, 2021
- 11
San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians
Managing Patients' Hypertension During the COVID-19 Era: What Happens with the ACE 2 Receptor During Infection? Do ACEI and ARBs Increase the Risk of COVID-19 Infection?
FEATURING
Christian Mende
- 48 views
- February 5, 2021